BCL2 and diffuse large B-cell lymphoma: However, the DLBCL lines that we derived to be venetoclax-resistant and retained wild-type BCL2 showed significantly increased sensitivity to mitochondrial ETC complex I inhibitors and an upregulation of genes in oxidative phosphorylation.